Rondol

Rondol

Flexible, disposable photocatalytic plastic films for the destruction of viruses

A Rondol vertical micro extruder, equipped with a slit die, was used to produce the first flexible, very thin, photocatalytic plastic film, produced by a scalable process (extrusion), for virus inactivation. Covid19 (SARS-CoV-2), influenzas A and B and other respiratory illnesses are spread by sneezing, coughing and talking; virus particles then settle on surfaces and …

Flexible, disposable photocatalytic plastic films for the destruction of viruses Read More »

Development of a Hot-Melt-Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns

We are proud to share that our Rondol twin screw micro extruder can be adapted successfully to produce pharmaceutically usable fibres and yarns. Cost-effective modifications to our hot melt extruder – such as a 3D printed custom die – allow the production of high-quality fibers with a high tensile strength to be created that further …

Development of a Hot-Melt-Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns Read More »

Research: improvements to recycled poly(lactic acid) (PLA)

Recycling plastics is a crucial solution to environmental and resource availability problems. In this study on PLA, yerba mate nanoparticles were added to improve the performance and suitability of recycled PLA for applications such as food packaging. The Rondol Vertical All-In-One microextruder was used to process the PLA pellets. Read the full MDPI article here: …

Research: improvements to recycled poly(lactic acid) (PLA) Read More »

Research on polymeric blends in bone scaffolds

The Rondol vertical twin screw microextruder was used in research on advanced polymeric blends intended to overcome limitations in the current treatment of bone disorders. New compositions of printed bone scaffolds provide increase biocompatibility and support better bone cell attachment and proliferation. Read the full PubMed article here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964080/

Continuous manufacture to meet increased demand during a global pandemic: From bench to pilot scale

During pandemics and global crises, drug shortages become critical as a result of increased demand, shortages in personnel and lockdown restrictions that disrupt the supply chain. The pharmaceutical industry is therefore moving towards continuous manufacturing instead of conventional batch manufacturing involving numerous steps, that normally occur at different sites. Using Hydroxychloroquine Sulphate (HCQS) as the …

Continuous manufacture to meet increased demand during a global pandemic: From bench to pilot scale Read More »

Rondol partners with Arkema and Concordia University for battery innovation

Rondol Industrie has signed a five-year collaborative agreement with world-leading material sciences company Arkema and Concordia University in Canada. The partnership between the three entities promises to stimulate progress in the battery industry, as the use of renewable energy in society continues to increase. The partners are combining efforts to explore the benefits of an …

Rondol partners with Arkema and Concordia University for battery innovation Read More »

A Comparative Overview of Hot Melt Extrusion and Spray Drying in Pharmaceutical Manufacturing

Hot Melt Extrusion and Spray Drying are two distinct technologies employed in the pharmaceutical industry to enhance drug formulations. Let’s take a closer look at these methods and compare their key features. In terms of common strong points, both Hot Melt Extrusion and Spray Drying share the goal of improving the release profile of all …

A Comparative Overview of Hot Melt Extrusion and Spray Drying in Pharmaceutical Manufacturing Read More »

Extrusion for pharma applications: An update

Victoire de Margerie (CEO of Rondol), Pascal Boulet (Institut Jean Lamour), and MaĂ«l Gallas (Rondol) published a new article in SPE Polymers about our current research and development on hot-melt extrusion (HME) for drug delivery and pharmaceutical formulation. Unfortunately, a large percentage of marketed drugs (40%) and those in the development pipeline (90%) are poorly water …

Extrusion for pharma applications: An update Read More »